Market cap
₹155 Cr
Revenue (TTM)
₹383 Cr
P/E Ratio
33
P/B Ratio
2
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -21.09 | 0.19 | 17.76 | 1.52 | 6.64 |
| EBIT | -0.96 | -56.24 | -42.55 | -5.95 | 27.18 |
| Net Profit | 21.44 | -60.66 | -50.19 | -6.23 | 35.82 |
| EPS | 21.45 | -60.68 | -50.20 | -6.23 | 35.82 |
| Book Value | -- | -- | 13.74 | 20.60 | 29.67 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-25 | Mar-24 |
| EBIT-Margin
| 5.42 | 5.36 | 2.07 | 4.53 | 6.57 |
| Net Margin
| 3.72 | 3.69 | 1.23 | 3.13 | 4.56 |
| Return on equity
| 19.17 | 26.02 | 6.26 | 12.87 | 20.21 |
| Return on Capital
| 17.41 | 20.84 | -- | 13.46 | 18.99 |
| Return on Assets
| 9.93 | 11.99 | 3.59 | 7.30 | 11.04 |
| Debt to Equity (x)
| -- | -- | 0.01 | 0.54 | 0.31 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
MK Proteins
|
--
|
13.46
|
18.99
|
19.78
|
22.82
|
|
Peer Median
|
--
|
13.66
|
--
|
17.67
|
--
|
ROE
6.26
Lower than Peers by 2.78
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
MK Proteins
|
6.26
|
12.87
|
20.21
|
24.44
|
29.54
|
|
Peer Median
|
9.04
|
14.72
|
--
|
19.14
|
--
|
ROA
3.59
Lower than Peers by 1.13
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
MK Proteins
|
3.59
|
7.30
|
11.04
|
11.45
|
13.32
|
|
Peer Median
|
4.72
|
4.99
|
--
|
7.87
|
--
|
EBIT Margin
2.07
Lower than Peers by 0.33
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
MK Proteins
|
2.07
|
4.53
|
6.57
|
5.15
|
5.70
|
|
Peer Median
|
2.40
|
5.13
|
--
|
2.48
|
--
|
Net Margin
1.23
Lower than Peers by 0.13
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
MK Proteins
|
1.23
|
3.13
|
4.56
|
3.47
|
3.97
|
|
Peer Median
|
1.36
|
1.61
|
--
|
2.12
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
MK Proteins
|
--
|
3.26
|
4.78
|
3.73
|
4.34
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
17.76
Lower than Peers by 4.50
Year on year growth in net sales
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
MK Proteins
|
17.76
|
9.08
|
-22.06
|
23.05
|
-17.75
|
|
Peer Median
|
22.25
|
53.50
|
--
|
22.74
|
--
|
EBIT Growth
-42.55
Lower than Peers by 65.71
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
MK Proteins
|
-42.55
|
-24.73
|
-0.55
|
11.14
|
-3.30
|
|
Peer Median
|
23.16
|
453.13
|
--
|
48.50
|
--
|
Net Profit Growth
-50.19
Lower than Peers by 80.05
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
MK Proteins
|
-50.19
|
-25.10
|
2.54
|
7.37
|
-1.97
|
|
Peer Median
|
29.86
|
699.41
|
--
|
45.95
|
--
|
EPS Growth
-50.20
Lower than Peers by 60.06
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
MK Proteins
|
-50.20
|
-25.11
|
2.54
|
7.37
|
-1.99
|
|
Peer Median
|
9.86
|
368.20
|
--
|
100.00
|
--
|
Book Value Growth
--
--
Year on year growth in book value per share
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
MK Proteins
|
--
|
13.74
|
22.48
|
25.91
|
34.99
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.01
Lower than Peers by 0.01
Total debt / Net worth
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
MK Proteins
|
0.01
|
0.54
|
0.31
|
0.89
|
0.93
|
|
Peer Median
|
0.03
|
0.90
|
--
|
0.79
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
MK Proteins
|
--
|
0.53
|
0.31
|
0.84
|
0.86
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
2.25
Higher than Peers by 0.57
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
MK Proteins
|
2.25
|
1.98
|
2.44
|
1.94
|
1.88
|
|
Peer Median
|
1.68
|
1.76
|
--
|
1.58
|
--
|
Quick Ratio
0.16
Lower than Peers by 0.86
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
MK Proteins
|
0.16
|
0.15
|
0.24
|
0.57
|
0.74
|
|
Peer Median
|
1.02
|
1.04
|
--
|
1.18
|
--
|
Interest Coverage
4.91
Higher than Peers by 0.48
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
MK Proteins
|
4.91
|
10.84
|
15.02
|
8.90
|
16.82
|
|
Peer Median
|
4.44
|
2.75
|
--
|
4.09
|
--
|
Operating Efficiency
Debtors to sales
0.55
Lower than Peers by 4.10
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
MK Proteins
|
0.55
|
0.52
|
1.46
|
5.10
|
11.41
|
|
Peer Median
|
4.65
|
6.00
|
--
|
6.95
|
--
|
Asset Turnover
2.93
Higher than Peers by 0.72
Sales / Average Total Assets
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
MK Proteins
|
2.93
|
2.33
|
2.42
|
3.30
|
3.35
|
|
Peer Median
|
2.21
|
4.65
|
--
|
5.13
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
MK Proteins
|
--
|
3.39
|
14.57
|
26.19
|
35.56
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
MK Proteins
|
--
|
129.74
|
111.73
|
69.99
|
62.38
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
MK Proteins
|
--
|
23.45
|
13.74
|
6.29
|
10.50
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
MK Proteins
|
--
|
109.67
|
112.57
|
89.89
|
87.44
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
33.01
Higher than Peers by 15.85
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
MK Proteins
|
33.01
|
27.00
|
33.08
|
--
|
0.09
|
|
Peer Median
|
17.16
|
22.72
|
--
|
25.17
|
--
|
Price / Book Value
2.00
Higher than Peers by 0.20
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
MK Proteins
|
2.00
|
3.26
|
6.07
|
--
|
2.02
|
|
Peer Median
|
1.80
|
3.25
|
--
|
3.66
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
MK Proteins
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
21.98
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
MK Proteins
|
21.98
|
20.39
|
22.80
|
3.22
|
7.36
|
|
Peer Median
|
--
|
32.07
|
--
|
15.13
|
--
|
Market Cap
155
Lower than Peers by 264
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
MK Proteins
|
155
|
227
|
371
|
--
|
80
|
|
Peer Median
|
419
|
478
|
--
|
302
|
--
|